<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">352858</id>
  <title nil="true"/>
  <common-name>2-[4-(2-benzhydryloxyethyl)piperazin-1-yl]-1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]ethanone</common-name>
  <description>2-[4-(2-benzhydryloxyethyl)piperazin-1-yl]-1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]ethanone is a chemical compound with the formula C33H40N4O4. With an average molecular weight of 556.70 g/mol, 2-[4-(2-benzhydryloxyethyl)piperazin-1-yl]-1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]ethanone is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>3046288</pubchem-id>
  <chemical-formula>C33H40N4O4</chemical-formula>
  <weight>556.7</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T19:24:06Z</created-at>
  <updated-at type="dateTime">2026-08-31T19:24:06Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=CC=C3)CC(=O)N4CCN(CC4)CC5=CC6=C(C=C5)OCO6</moldb-smiles>
  <moldb-formula>C33H40N4O4</moldb-formula>
  <moldb-inchi>InChI=1S/C33H40N4O4/c38-32(37-19-17-35(18-20-37)24-27-11-12-30-31(23-27)41-26-40-30)25-36-15-13-34(14-16-36)21-22-39-33(28-7-3-1-4-8-28)29-9-5-2-6-10-29/h1-12,23,33H,13-22,24-26H2</moldb-inchi>
  <moldb-inchikey>LKNCMKRFJKKCLO-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">556.3049558</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM348751</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[4-(2-benzhydryloxyethyl)piperazin-1-yl]-1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]ethanone</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Diphenylmethanes</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0303142</sync-id>
  <structure-inchikey>LKNCMKRFJKKCLO-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4004000000000000002080000000000000000000000000000000000000000000000004000000020800000000000000000400000000000040000000000000000000000400000000800000000000000000002080000000010000000000248000800000800001000000000000000010000000000002010000000000000000004000001000000000000080000000000000400000000000010000000000000000000000000000c00200000400040008000000000000000000000000a000000020000000000000000404000000000000010000000000000000000000000220041000010080000000001000010040000000400400080000000000000000004000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAApAAAALgAAAIABBgBgAAAAAgIGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:50:33Z</structure-indexed-at>
</compound>
